A large number of retroviruses induce tumors at high frequency when injected into appropriate hosts. Most of these viruses act by directly interfering with normal cellular growth and differentiation and, because they also transform cells in vitro, the cell-virus interactions can be studied under controlled conditions. Nearly all of these transforming viruses carry gene(s) derived from normal cellular DNA called onc genes that encode the proteins that are responsible for cellular transformation. Because onc genes are derived from normal cellular DNA, understanding their mode of action in a viral system would be an important step toward understanding their role, not only in oncogenesis but also in normal growth and development. We are examining this question using a Abelson virus (A-MuLV) model system and a genetic approach. A-MuLV transforms some fibroblast of lymphosarcomas in mice. Through the isolation of variant A- MuLV strains, it has been possible to separate viral functions required for fibroblast and lymphoid transformation as well as those required for high efficiency lymphoid transformation in vitro and in vivo. We plan to use these mutants and isolate others to determine the mechanism(s) that control A-MuLV-cell interaction.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA024220-10
Application #
3166367
Study Section
Experimental Virology Study Section (EVR)
Project Start
1978-09-01
Project End
1992-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
10
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Yi, Chae-ryun; Rosenberg, Naomi (2008) Mutations affecting the MA portion of the v-Abl protein reveal a conserved role of Gag in Abelson murine leukemia virus (MLV) and Moloney MLV. J Virol 82:5307-15
Yi, Chae-Ryun; Rosenberg, Naomi (2007) Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein. J Virol 81:9461-8
Marchlik, Erica; Kalman, Richard; Rosenberg, Naomi (2005) Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus. J Virol 79:11618-26
Kharas, Michael G; Deane, Jonathan A; Wong, Stephane et al. (2004) Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells. Blood 103:4268-75
Warren, David; Griffin, Deborah S; Mainville, Celine et al. (2003) The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus. J Virol 77:4617-25
Unnikrishnan, Indira; Rosenberg, Naomi (2003) Absence of p53 complements defects in Abelson murine leukemia virus signaling. J Virol 77:6208-15
Afar, D E; Han, L; McLaughlin, J et al. (1997) Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1. Immunity 6:773-82
Parmar, K; Rosenberg, N (1996) Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation. J Virol 70:1009-15
Raffel, G D; Parmar, K; Rosenberg, N (1996) In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction. J Biol Chem 271:4640-5
Wang, L C; Chen, Y Y; Rosenberg, N (1995) Pre-B-cells transformed by ts Abelson virus rearrange kappa and lambda [correction of gamma] genes in early G1. Curr Top Microbiol Immunol 194:355-61

Showing the most recent 10 out of 23 publications